MDxHealth (MDXH) Revenue (2021 - 2026)

MDxHealth has disclosed Revenue across 6 years of filings, most recently posting $27.4 million for Q1 2026.

• Revenue for Q1 2026 came in at $27.4 million, up 12.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $64.0 billion (up 67616.0% YoY), and the FY2025 annual result was $107.9 million, up 19.8% from the prior year.
• Revenue came in at $27.4 million for Q1 2026 at MDxHealth, down from $29.5 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $63.9 billion in Q2 2025 to a low of -$6.1 million in Q2 2022.
• The 5-year median for Revenue is $19.8 million (2024), against an average of $3.8 billion.
• Across the five-year window, Revenue jumped 288324.57% in 2025 and climbed 12.74% in 2026, its largest moves.
• MDxHealth's Revenue stood at $12.9 million in 2022, then soared by 50.48% to $19.4 million in 2023, then gained by 27.53% to $24.7 million in 2024, then increased by 19.43% to $29.5 million in 2025, then declined by 7.31% to $27.4 million in 2026.
• The last three Revenue figures came in at $27.4 million (Q1 2026), $29.5 million (Q4 2025), and $27.4 million (Q3 2025), per Business Quant data.